Latest News and Press Releases
HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)
December 07, 2024 15:30 ET
|
HII
NEWPORT NEWS, Va., Dec. 07, 2024 (GLOBE NEWSWIRE) -- HII (NYSE: HII) today christened Virginia-class submarine Arkansas (SSN 800) at the company’s Newport News Shipbuilding (NNS) division. “Today...
Admirals Group AS Announces a Sale of its Australian Subsidiary
December 07, 2024 15:10 ET
|
Admirals Group AS
Admirals Group AS has entered into an agreement to sell its wholly owned subsidiary, Admirals AU PTY Ltd (Australia), a licensed investment company, to a non-related party, as part of the Admirals...
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages TMC the metals company Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMC
December 07, 2024 14:58 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TMC the metals company Inc. (NASDAQ: TMC) between May 12,...
Marqeta, Inc. Announcement: If You Have Suffered Losses in Marqeta, Inc. (NASDAQ: MQ), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
December 07, 2024 14:01 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Marqeta,...
Galapagos Announces Encouraging New Results from Ongoing Phase 1/2 Study of CD19 CAR T-Cell Therapy, GLPG5101, in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
December 07, 2024 12:30 ET
|
Galapagos NV
Data from the ongoing Phase 1/2 ATALANTA-1 study in a heavily pretreated R/R NHL patient population demonstrate high antitumor activity and an encouraging safety profile in all NHL subtypes...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of AE, EVGR, CCRN and BRKH
December 07, 2024 12:00 ET
|
Monteverde & Associates PC
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...
Y-mAbs Presents SADA Platform Preclinical Data and Trial in Progress Posters at the 2024 American Society Hematology (ASH) Annual Meeting
December 07, 2024 12:00 ET
|
Y-mAbs Therapeutics, Inc.
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and...
$HAREHOLDER INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Mergers of RKDA, ENLC, and SKGR
December 07, 2024 12:00 ET
|
Monteverde & Associates PC
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by...
ROSEN, LEADING INVESTOR COUNSEL, Encourages Warner Bros. Discovery, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WBD
December 07, 2024 11:35 ET
|
The Rosen Law Firm PA
NEW YORK, Dec. 07, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Warner Bros. Discovery, Inc. (NASDAQ: WBD) between February...
Beam Therapeutics Announces New Data from BEACON Phase 1/2 Clinical Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
December 07, 2024 11:30 ET
|
Beam Therapeutics
All Seven Patients Treated with BEAM-101 Achieved Hemoglobin F (HbF) Induction of >60%, Hemoglobin S (HbS) Reduction to <40%, and Resolution of Anemia Post-BEAM-101 Treatment Initial Safety...
- December 07, 2024 15:30 ET HII Christens Virginia-Class Attack Submarine Arkansas (SSN 800)
- December 07, 2024 00:32 ET Sallar Announces the Launch of Its Decentralized Computing Application